Zhejiang Medicine Co., Ltd. (SHA:600216)

Zhejiang Medicine Revenue

Zhejiang Medicine had revenue of 1.86B CNY in the quarter ending September 30, 2026, a decrease of -21.60%. This brings the company's total for the last twelve months to 8.43B, down -5.88% year-over-year. In the year 2025, Zhejiang Medicine had annual revenue of 8.88B, down -5.28%. That makes Zhejiang Medicine the 6,669th largest company in the world by revenue and 934th in China.

• Revenue (ttm): 8.43B
• Revenue Growth: -5.88%
• P/S Ratio: 1.25
• Revenue / Employee: 1.56M
• Employees: 5,417
• Market Cap: 10.56B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine 4.46B 50.5%
• Life Nutrition 4.33B 49.0%
• Others 44.51M 0.5%

By Geography

Chart

• China 5.96B 59.4%
• Overseas 4.08B 40.6%

Fiscal year ended Dec 31, 2025 See the full Zhejiang Medicine breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.88B	-494.61M	-5.28%
Dec 31, 2024	9.38B	1.58B	20.29%
Dec 31, 2023	7.79B	-321.66M	-3.96%
Dec 31, 2022	8.12B	-1.01B	-11.10%
Dec 31, 2021	9.13B	1.80B	24.60%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error